Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and plx 4720

erlotinib hydrochloride has been researched along with plx 4720 in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(plx 4720)		Trials
(plx 4720)		Recent Studies (post-2010) (plx 4720)
4,3537863,0331631151

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)plx 4720 (IC50)
Chain A, B-Raf proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.16
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1Homo sapiens (human)0.16
Chain A, Basic fibroblast growth factor receptor 1Homo sapiens (human)0.16
PirinHomo sapiens (human)0.67
Aurora kinase AHomo sapiens (human)1.8466
Mitogen-activated protein kinase kinase kinase kinase 4Homo sapiens (human)1.8466
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.0065
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)1.8466
Fibroblast growth factor receptor 1Homo sapiens (human)1.8466
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)1.3575
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.8593
Vascular endothelial growth factor receptor 2Homo sapiens (human)1.3575
Tyrosine-protein kinase CSKHomo sapiens (human)1.8466
Tyrosine-protein kinase FRKHomo sapiens (human)1.3575
Focal adhesion kinase 1Homo sapiens (human)1.8466
Protein-tyrosine kinase 6Homo sapiens (human)1.3575

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brors, B; Haibe-Kains, B; Kurilov, R1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and plx 4720

ArticleYear
Assessment of modelling strategies for drug response prediction in cell lines and xenografts.
    Scientific reports, 2020, 02-18, Volume: 10, Issue:1

    Topics: Animals; Biomarkers, Pharmacological; Cell Line, Tumor; Erlotinib Hydrochloride; Humans; Imidazoles; Indoles; Lapatinib; Machine Learning; Mice; Neoplasms; Organ Specificity; Paclitaxel; Piperazines; Prognosis; Pyrimidines; Sorafenib; Sulfonamides; Xenograft Model Antitumor Assays

2020